Founded in 2018 and headquartered in Austria with subsidiaries in Germany and Switzerland, TT medic is active in precision medical injection molding, specializing as a contract development and manufacturing organization in cleanroom processing of high-quality polymer components. The company covers almost the entire value chain, positioning itself as a fully integrated partner for medtech original equipment manufacturers. Strong engineering and research and development capabilities allow TT medic to support clients at an early stage of their product development and thus foster product innovation.

Yan Henrichs, Head of Private Debt DACH at LGT Capital Partners, commented: “We believe that TT medic is well positioned to continue its successful growth trajectory, building on its strong client relationships, medtech component expertise and highly complex solution offering. We are delighted to partner with Trill Impact as we share a common investment strategy to drive sustainable growth and generate social or environmental impact in selected industries."

Korbinian Knoblach, Partner and Co-Head of Private Equity at Trill Impact Advisory, said: “We are excited to collaborate with a partner that shares our vision for the company's future. The LGT Private Debt team quickly recognized the strong potential of TT medic. We appreciate their commitment to providing an effective financing solution that meets our growth ambitions and those of TT medic’s management team.”

Private debt is one of LGT Capital Partners’ areas of expertise in the field of private markets. The team has an average of 13 years of industry experience and is based in Paris, London and Frankfurt am Main. It has invested more than EUR 5.6 billion since 2005. As a specialist in the European private debt market, it arranged the first unitranche transaction in Europe in 2007.